| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Neoplasms, Glandular and Epithelial | 3 | 2017 | 39 | 1.02 | Why? |
| Vaccines, Inactivated | 5 | 2021 | 1562 | 0.80 | Why? |
| Pterocarpans | 1 | 2017 | 2 | 0.74 | Why? |
| Concanavalin A | 1 | 2017 | 19 | 0.70 | Why? |
| Wnt Signaling Pathway | 2 | 2017 | 87 | 0.69 | Why? |
| ADAM Proteins | 1 | 2017 | 43 | 0.69 | Why? |
| Calpain | 1 | 2017 | 39 | 0.69 | Why? |
| Thymidine Kinase | 1 | 2016 | 11 | 0.68 | Why? |
| Toll-Like Receptor 5 | 1 | 2017 | 38 | 0.68 | Why? |
| Cell Movement | 3 | 2017 | 695 | 0.67 | Why? |
| Ovarian Neoplasms | 3 | 2017 | 465 | 0.67 | Why? |
| Gadolinium DTPA | 1 | 2016 | 45 | 0.66 | Why? |
| beta Catenin | 1 | 2017 | 78 | 0.66 | Why? |
| Osteosarcoma | 1 | 2017 | 83 | 0.65 | Why? |
| Osteopontin | 1 | 2017 | 96 | 0.63 | Why? |
| Doxorubicin | 2 | 2018 | 313 | 0.62 | Why? |
| Epithelial-Mesenchymal Transition | 2 | 2017 | 242 | 0.61 | Why? |
| STAT3 Transcription Factor | 1 | 2017 | 268 | 0.60 | Why? |
| Hyperthermia, Induced | 1 | 2016 | 106 | 0.59 | Why? |
| Natural Killer T-Cells | 1 | 2017 | 191 | 0.58 | Why? |
| Diathermy | 1 | 2014 | 13 | 0.58 | Why? |
| Intranuclear Inclusion Bodies | 1 | 2014 | 5 | 0.57 | Why? |
| Spinocerebellar Ataxias | 1 | 2014 | 20 | 0.55 | Why? |
| Cell Adhesion Molecules | 1 | 2017 | 472 | 0.55 | Why? |
| Transfusion Reaction | 1 | 2016 | 245 | 0.54 | Why? |
| Urinary Bladder Neoplasms | 2 | 2017 | 614 | 0.54 | Why? |
| Transfection | 1 | 2016 | 864 | 0.51 | Why? |
| Peptides | 2 | 2017 | 2513 | 0.51 | Why? |
| Cell Line, Tumor | 8 | 2018 | 3608 | 0.50 | Why? |
| Cell Proliferation | 6 | 2018 | 1973 | 0.50 | Why? |
| Membrane Proteins | 3 | 2017 | 1733 | 0.48 | Why? |
| Repressor Proteins | 1 | 2014 | 232 | 0.47 | Why? |
| Chemical and Drug Induced Liver Injury | 1 | 2017 | 451 | 0.47 | Why? |
| Rabies virus | 2 | 2009 | 92 | 0.47 | Why? |
| Genetic Therapy | 1 | 2016 | 409 | 0.46 | Why? |
| Drug Therapy | 1 | 2014 | 280 | 0.46 | Why? |
| MicroRNAs | 3 | 2018 | 1787 | 0.41 | Why? |
| Contrast Media | 1 | 2016 | 1011 | 0.40 | Why? |
| Breast Neoplasms | 3 | 2018 | 3633 | 0.38 | Why? |
| Xenograft Model Antitumor Assays | 3 | 2019 | 274 | 0.36 | Why? |
| Antibodies, Neutralizing | 5 | 2021 | 25288 | 0.36 | Why? |
| Drug Evaluation, Preclinical | 1 | 2020 | 3347 | 0.36 | Why? |
| Rabies | 1 | 2009 | 113 | 0.36 | Why? |
| Down-Regulation | 3 | 2017 | 1416 | 0.33 | Why? |
| Neoplasm Invasiveness | 3 | 2017 | 582 | 0.32 | Why? |
| Gene Knockdown Techniques | 2 | 2017 | 347 | 0.32 | Why? |
| Antineoplastic Agents | 3 | 2019 | 3550 | 0.30 | Why? |
| Mice, Inbred BALB C | 5 | 2020 | 5814 | 0.30 | Why? |
| Nuclear Proteins | 2 | 2018 | 321 | 0.29 | Why? |
| Up-Regulation | 3 | 2017 | 2249 | 0.29 | Why? |
| Early Detection of Cancer | 1 | 2016 | 1956 | 0.27 | Why? |
| Receptors, Virus | 1 | 2021 | 5659 | 0.27 | Why? |
| Promoter Regions, Genetic | 2 | 2017 | 823 | 0.25 | Why? |
| Mice | 8 | 2020 | 21357 | 0.25 | Why? |
| Magnetic Resonance Imaging | 3 | 2016 | 6551 | 0.25 | Why? |
| Thrombocytopenia | 1 | 2016 | 2093 | 0.25 | Why? |
| Animals | 20 | 2021 | 78931 | 0.24 | Why? |
| Gene Expression Regulation, Neoplastic | 3 | 2017 | 1014 | 0.24 | Why? |
| Colorectal Neoplasms | 1 | 2016 | 1884 | 0.24 | Why? |
| Rats | 3 | 2020 | 2764 | 0.22 | Why? |
| Immunohistochemistry | 3 | 2017 | 2275 | 0.22 | Why? |
| Lung Neoplasms | 1 | 2017 | 3228 | 0.21 | Why? |
| Mice, Nude | 2 | 2018 | 340 | 0.20 | Why? |
| Kidney Failure, Chronic | 1 | 2016 | 3222 | 0.20 | Why? |
| Immunization, Passive | 3 | 2021 | 10067 | 0.20 | Why? |
| Rabbits | 2 | 2020 | 1171 | 0.20 | Why? |
| Proto-Oncogene Proteins c-met | 1 | 2019 | 40 | 0.20 | Why? |
| Endosperm | 1 | 2018 | 5 | 0.20 | Why? |
| Guinea Pigs | 1 | 2020 | 420 | 0.19 | Why? |
| Pyruvate Kinase | 1 | 2018 | 16 | 0.19 | Why? |
| Kaplan-Meier Estimate | 3 | 2017 | 4260 | 0.19 | Why? |
| Guided Tissue Regeneration | 1 | 2018 | 6 | 0.19 | Why? |
| alpha-MSH | 1 | 2018 | 17 | 0.19 | Why? |
| Receptor, Notch1 | 1 | 2018 | 21 | 0.19 | Why? |
| Sciatic Nerve | 1 | 2018 | 26 | 0.19 | Why? |
| Viral Vaccines | 1 | 2020 | 7560 | 0.18 | Why? |
| Nerve Regeneration | 1 | 2018 | 26 | 0.18 | Why? |
| Antibodies, Viral | 7 | 2021 | 51949 | 0.18 | Why? |
| G1 Phase Cell Cycle Checkpoints | 2 | 2017 | 26 | 0.18 | Why? |
| Twist-Related Protein 1 | 1 | 2017 | 7 | 0.18 | Why? |
| Disease Models, Animal | 6 | 2020 | 10998 | 0.18 | Why? |
| Mitogen-Activated Protein Kinase 7 | 1 | 2017 | 6 | 0.18 | Why? |
| Rats, Wistar | 1 | 2020 | 621 | 0.18 | Why? |
| Oxazolidinones | 1 | 2017 | 49 | 0.18 | Why? |
| Chromatin Assembly Factor-1 | 1 | 2017 | 2 | 0.18 | Why? |
| Urinary Diversion | 1 | 2017 | 26 | 0.18 | Why? |
| Cell Survival | 3 | 2018 | 1581 | 0.18 | Why? |
| Thinness | 1 | 2018 | 99 | 0.17 | Why? |
| Antigens, CD34 | 1 | 2018 | 125 | 0.17 | Why? |
| Oryza | 1 | 2018 | 86 | 0.17 | Why? |
| Wnt Proteins | 1 | 2017 | 38 | 0.17 | Why? |
| Citrus | 1 | 2017 | 29 | 0.17 | Why? |
| Genes, Transgenic, Suicide | 1 | 2016 | 4 | 0.17 | Why? |
| Genome, Plant | 1 | 2017 | 41 | 0.17 | Why? |
| Cadherins | 1 | 2017 | 145 | 0.17 | Why? |
| Mink | 1 | 2021 | 399 | 0.17 | Why? |
| Protein Processing, Post-Translational | 1 | 2020 | 634 | 0.17 | Why? |
| Scoliosis | 1 | 2017 | 45 | 0.17 | Why? |
| Rotator Cuff | 1 | 2016 | 15 | 0.17 | Why? |
| RNA Interference | 2 | 2017 | 534 | 0.17 | Why? |
| Homocysteine | 1 | 2017 | 83 | 0.17 | Why? |
| Immunoglobulin G | 1 | 2021 | 21571 | 0.16 | Why? |
| Cell Cycle Checkpoints | 1 | 2017 | 126 | 0.16 | Why? |
| HT29 Cells | 1 | 2016 | 108 | 0.16 | Why? |
| Viral Structural Proteins | 1 | 2020 | 491 | 0.16 | Why? |
| Rotator Cuff Injuries | 1 | 2016 | 32 | 0.16 | Why? |
| Arthroscopy | 1 | 2016 | 46 | 0.16 | Why? |
| MCF-7 Cells | 1 | 2016 | 199 | 0.16 | Why? |
| Plant Proteins | 1 | 2018 | 194 | 0.16 | Why? |
| Myocytes, Smooth Muscle | 1 | 2017 | 127 | 0.16 | Why? |
| Vero Cells | 4 | 2021 | 14117 | 0.16 | Why? |
| Biopsy, Needle | 1 | 2017 | 303 | 0.15 | Why? |
| Erythropoietin | 1 | 2017 | 167 | 0.15 | Why? |
| Cystectomy | 1 | 2017 | 218 | 0.15 | Why? |
| Evolution, Molecular | 1 | 2009 | 3691 | 0.15 | Why? |
| Decompression, Surgical | 1 | 2016 | 114 | 0.15 | Why? |
| Drug Resistance, Multiple | 1 | 2016 | 156 | 0.15 | Why? |
| Macaca fascicularis | 1 | 2020 | 1009 | 0.15 | Why? |
| Chitosan | 1 | 2018 | 196 | 0.15 | Why? |
| Mice, Knockout | 2 | 2018 | 1815 | 0.14 | Why? |
| TATA-Box Binding Protein | 1 | 2014 | 3 | 0.14 | Why? |
| Hematopoietic Stem Cells | 1 | 2018 | 321 | 0.14 | Why? |
| PC12 Cells | 1 | 2014 | 33 | 0.14 | Why? |
| Sequence Analysis, DNA | 2 | 2017 | 2830 | 0.14 | Why? |
| Alkaloids | 1 | 2017 | 255 | 0.14 | Why? |
| Ubiquitin-Protein Ligases | 1 | 2017 | 249 | 0.14 | Why? |
| Cyclic AMP Response Element-Binding Protein | 1 | 2014 | 29 | 0.14 | Why? |
| Sialoglycoproteins | 1 | 2014 | 24 | 0.14 | Why? |
| Random Allocation | 1 | 2017 | 773 | 0.14 | Why? |
| Reference Values | 1 | 2017 | 795 | 0.13 | Why? |
| Graphite | 1 | 2018 | 318 | 0.13 | Why? |
| Genetic Association Studies | 1 | 2017 | 559 | 0.13 | Why? |
| Fetal Blood | 1 | 2018 | 573 | 0.13 | Why? |
| Cell Line | 3 | 2021 | 12040 | 0.13 | Why? |
| Neoplasm Metastasis | 1 | 2017 | 682 | 0.13 | Why? |
| Plasmids | 1 | 2017 | 840 | 0.13 | Why? |
| Heat-Shock Proteins | 1 | 2016 | 226 | 0.13 | Why? |
| Spike Glycoprotein, Coronavirus | 2 | 2021 | 37182 | 0.13 | Why? |
| Hepatocytes | 1 | 2017 | 549 | 0.13 | Why? |
| HSP70 Heat-Shock Proteins | 1 | 2014 | 113 | 0.13 | Why? |
| Immunization Schedule | 1 | 2020 | 1305 | 0.13 | Why? |
| Plasma Exchange | 1 | 2020 | 763 | 0.13 | Why? |
| Brain Injuries, Traumatic | 1 | 2018 | 381 | 0.12 | Why? |
| Drug Resistance, Neoplasm | 1 | 2016 | 447 | 0.12 | Why? |
| RNA, Small Interfering | 1 | 2017 | 817 | 0.12 | Why? |
| DNA Methylation | 1 | 2017 | 688 | 0.12 | Why? |
| Signal Transduction | 3 | 2018 | 7207 | 0.12 | Why? |
| Virion | 1 | 2020 | 1444 | 0.12 | Why? |
| Antigens, CD | 1 | 2017 | 984 | 0.12 | Why? |
| Postoperative Care | 1 | 2017 | 755 | 0.12 | Why? |
| Female | 20 | 2021 | 380317 | 0.11 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.11 | Why? |
| Epigenesis, Genetic | 1 | 2017 | 711 | 0.11 | Why? |
| Pyrimidines | 1 | 2019 | 1557 | 0.11 | Why? |
| Humans | 28 | 2021 | 930598 | 0.10 | Why? |
| Radiography | 2 | 2017 | 1576 | 0.10 | Why? |
| Open Reading Frames | 1 | 2017 | 1898 | 0.10 | Why? |
| RNA-Binding Proteins | 1 | 2017 | 1022 | 0.10 | Why? |
| Macaca mulatta | 1 | 2020 | 3716 | 0.10 | Why? |
| Convalescence | 1 | 2021 | 2829 | 0.10 | Why? |
| Apoptosis | 2 | 2018 | 2335 | 0.10 | Why? |
| Mice, Inbred C57BL | 2 | 2018 | 5542 | 0.10 | Why? |
| Immunity, Humoral | 2 | 2021 | 4849 | 0.10 | Why? |
| Male | 14 | 2021 | 367725 | 0.10 | Why? |
| Double-Blind Method | 1 | 2020 | 5988 | 0.10 | Why? |
| Cells, Cultured | 2 | 2018 | 5835 | 0.09 | Why? |
| Base Sequence | 1 | 2017 | 3581 | 0.09 | Why? |
| Immunologic Memory | 1 | 2021 | 3362 | 0.09 | Why? |
| Carcinoma, Hepatocellular | 1 | 2019 | 1222 | 0.09 | Why? |
| Phylogeny | 3 | 2020 | 13341 | 0.09 | Why? |
| Flow Cytometry | 1 | 2017 | 2393 | 0.09 | Why? |
| Pyrazoles | 1 | 2019 | 1791 | 0.09 | Why? |
| Sequence Homology | 1 | 2009 | 448 | 0.09 | Why? |
| Hepacivirus | 1 | 2017 | 1509 | 0.09 | Why? |
| Gene Expression Regulation, Plant | 2 | 2018 | 110 | 0.09 | Why? |
| Blood Donors | 1 | 2021 | 2956 | 0.09 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.08 | Why? |
| Rabies Vaccines | 1 | 2007 | 106 | 0.08 | Why? |
| Leukocytes, Mononuclear | 1 | 2017 | 2115 | 0.08 | Why? |
| Liver Neoplasms | 1 | 2019 | 1666 | 0.08 | Why? |
| Point Mutation | 1 | 2009 | 481 | 0.08 | Why? |
| Reconstructive Surgical Procedures | 1 | 2016 | 860 | 0.08 | Why? |
| Polymorphism, Genetic | 1 | 2014 | 1074 | 0.08 | Why? |
| Genetic Variation | 2 | 2017 | 3919 | 0.08 | Why? |
| Cluster Analysis | 2 | 2017 | 3001 | 0.08 | Why? |
| Macrophages | 1 | 2018 | 2784 | 0.08 | Why? |
| Longitudinal Studies | 1 | 2021 | 9893 | 0.07 | Why? |
| Inflammation Mediators | 1 | 2017 | 2654 | 0.07 | Why? |
| Blotting, Western | 2 | 2018 | 863 | 0.07 | Why? |
| Genomics | 1 | 2017 | 3118 | 0.07 | Why? |
| Immunogenicity, Vaccine | 1 | 2020 | 4624 | 0.07 | Why? |
| Glycoproteins | 1 | 2009 | 615 | 0.07 | Why? |
| Sex Factors | 1 | 2021 | 11014 | 0.07 | Why? |
| Molecular Sequence Data | 1 | 2009 | 3198 | 0.07 | Why? |
| Peptide Fragments | 1 | 2014 | 2075 | 0.06 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.06 | Why? |
| Genotype | 2 | 2017 | 4697 | 0.06 | Why? |
| Genetic Predisposition to Disease | 1 | 2017 | 4027 | 0.06 | Why? |
| Survival Rate | 1 | 2017 | 9206 | 0.06 | Why? |
| Brain Ischemia | 1 | 2017 | 2813 | 0.06 | Why? |
| China | 3 | 2021 | 50654 | 0.06 | Why? |
| African Americans | 1 | 2016 | 3363 | 0.05 | Why? |
| Inflammation | 3 | 2018 | 13255 | 0.05 | Why? |
| Structure-Activity Relationship | 2 | 2017 | 2219 | 0.05 | Why? |
| Cats | 1 | 2007 | 1890 | 0.05 | Why? |
| Middle Aged | 7 | 2020 | 270681 | 0.05 | Why? |
| Tropism | 1 | 2021 | 210 | 0.05 | Why? |
| Dogs | 1 | 2007 | 2529 | 0.05 | Why? |
| Adolescent | 3 | 2020 | 86841 | 0.05 | Why? |
| Adult | 5 | 2021 | 244371 | 0.05 | Why? |
| Viral Load | 1 | 2020 | 15850 | 0.05 | Why? |
| HSC70 Heat-Shock Proteins | 1 | 2017 | 3 | 0.05 | Why? |
| Cyclins | 1 | 2018 | 16 | 0.05 | Why? |
| Interleukin Receptor Common gamma Subunit | 1 | 2018 | 24 | 0.05 | Why? |
| Umbilical Veins | 1 | 2017 | 14 | 0.05 | Why? |
| S-Adenosylhomocysteine | 1 | 2017 | 23 | 0.05 | Why? |
| Antigens, Viral | 2 | 2020 | 6298 | 0.05 | Why? |
| Platelet-Derived Growth Factor | 1 | 2017 | 21 | 0.05 | Why? |
| Biotechnology | 1 | 2002 | 444 | 0.04 | Why? |
| Long Interspersed Nucleotide Elements | 1 | 2017 | 32 | 0.04 | Why? |
| Alu Elements | 1 | 2017 | 22 | 0.04 | Why? |
| Mice, Inbred NOD | 1 | 2018 | 134 | 0.04 | Why? |
| Disease Progression | 1 | 2017 | 13580 | 0.04 | Why? |
| Apomixis | 1 | 2017 | 1 | 0.04 | Why? |
| Reproduction, Asexual | 1 | 2017 | 1 | 0.04 | Why? |
| Indazoles | 1 | 2018 | 77 | 0.04 | Why? |
| Gene Targeting | 1 | 2017 | 34 | 0.04 | Why? |
| Pandemics | 3 | 2020 | 389249 | 0.04 | Why? |
| Porosity | 1 | 2018 | 185 | 0.04 | Why? |
| Chromosomes, Plant | 1 | 2017 | 19 | 0.04 | Why? |
| Intracranial Pressure | 1 | 2018 | 90 | 0.04 | Why? |
| Young Adult | 2 | 2020 | 93724 | 0.04 | Why? |
| Mice, SCID | 1 | 2018 | 225 | 0.04 | Why? |
| Genetic Linkage | 1 | 2017 | 87 | 0.04 | Why? |
| GTP Phosphohydrolases | 1 | 2017 | 89 | 0.04 | Why? |
| PTEN Phosphohydrolase | 1 | 2017 | 70 | 0.04 | Why? |
| Allosteric Regulation | 1 | 2017 | 134 | 0.04 | Why? |
| Glasgow Coma Scale | 1 | 2018 | 249 | 0.04 | Why? |
| Bioethics | 1 | 2002 | 253 | 0.04 | Why? |
| S-Adenosylmethionine | 1 | 2017 | 137 | 0.04 | Why? |
| Obesity | 1 | 2018 | 7388 | 0.04 | Why? |
| Muscle, Smooth, Vascular | 1 | 2017 | 86 | 0.04 | Why? |
| Viral Envelope Proteins | 1 | 2009 | 3539 | 0.04 | Why? |
| Tendinopathy | 1 | 2016 | 18 | 0.04 | Why? |
| Chromosome Mapping | 1 | 2017 | 178 | 0.04 | Why? |
| Cell Cycle | 1 | 2018 | 329 | 0.04 | Why? |
| Mitochondrial Proteins | 1 | 2017 | 152 | 0.04 | Why? |
| Hep G2 Cells | 1 | 2017 | 391 | 0.04 | Why? |
| Cord Blood Stem Cell Transplantation | 1 | 2018 | 143 | 0.04 | Why? |
| Surface Properties | 1 | 2018 | 448 | 0.04 | Why? |
| Zebrafish | 1 | 2017 | 181 | 0.04 | Why? |
| Shoulder Pain | 1 | 2016 | 36 | 0.04 | Why? |
| Recovery of Function | 2 | 2017 | 2461 | 0.04 | Why? |
| CpG Islands | 1 | 2017 | 230 | 0.04 | Why? |
| Virus Replication | 1 | 2017 | 14331 | 0.04 | Why? |
| Tissue Engineering | 1 | 2018 | 190 | 0.04 | Why? |
| Cattle | 1 | 2020 | 1336 | 0.04 | Why? |
| Primary Cell Culture | 1 | 2017 | 501 | 0.04 | Why? |
| Range of Motion, Articular | 1 | 2016 | 168 | 0.04 | Why? |
| Ileum | 1 | 2017 | 233 | 0.04 | Why? |
| Carrier State | 1 | 2007 | 2100 | 0.04 | Why? |
| Gene Ontology | 1 | 2017 | 391 | 0.04 | Why? |
| Environment | 1 | 2002 | 769 | 0.04 | Why? |
| Gene Expression Profiling | 2 | 2017 | 3788 | 0.04 | Why? |
| Tumor Suppressor Protein p53 | 1 | 2017 | 310 | 0.04 | Why? |
| Whole Exome Sequencing | 1 | 2017 | 437 | 0.04 | Why? |
| Rats, Sprague-Dawley | 1 | 2018 | 987 | 0.04 | Why? |
| Analysis of Variance | 1 | 2018 | 950 | 0.04 | Why? |
| Cytokines | 1 | 2017 | 15010 | 0.04 | Why? |
| Aged | 4 | 2020 | 215776 | 0.03 | Why? |
| Mutation | 3 | 2021 | 12376 | 0.03 | Why? |
| Heterocyclic Compounds, 3-Ring | 1 | 2017 | 275 | 0.03 | Why? |
| Stroke | 1 | 2017 | 8839 | 0.03 | Why? |
| Pain Measurement | 1 | 2016 | 533 | 0.03 | Why? |
| Brain Injuries | 1 | 2018 | 374 | 0.03 | Why? |
| Particle Size | 1 | 2018 | 1052 | 0.03 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.03 | Why? |
| Species Specificity | 1 | 2017 | 1356 | 0.03 | Why? |
| Adipose Tissue | 1 | 2018 | 612 | 0.03 | Why? |
| Gene Frequency | 1 | 2017 | 1210 | 0.03 | Why? |
| RNA, Viral | 1 | 2020 | 32276 | 0.03 | Why? |
| Alleles | 1 | 2017 | 1557 | 0.03 | Why? |
| Transcription Factors | 1 | 2017 | 784 | 0.03 | Why? |
| Treatment Outcome | 2 | 2016 | 51732 | 0.03 | Why? |
| Aged, 80 and over | 1 | 2020 | 88759 | 0.03 | Why? |
| Muscle, Skeletal | 1 | 2016 | 915 | 0.02 | Why? |
| Atherosclerosis | 1 | 2017 | 768 | 0.02 | Why? |
| Sulfonamides | 1 | 2018 | 1294 | 0.02 | Why? |
| Tumor Necrosis Factor-alpha | 1 | 2018 | 2483 | 0.02 | Why? |
| Phenotype | 1 | 2017 | 4037 | 0.02 | Why? |
| Fluorescent Antibody Technique | 1 | 2007 | 835 | 0.02 | Why? |
| Antiviral Agents | 1 | 2017 | 41703 | 0.02 | Why? |
| Gene Expression Regulation | 1 | 2017 | 4020 | 0.02 | Why? |
| Polymorphism, Single Nucleotide | 1 | 2017 | 3607 | 0.02 | Why? |
| Food Technology | 1 | 2002 | 14 | 0.02 | Why? |
| Biological Warfare | 1 | 2002 | 19 | 0.02 | Why? |
| Nature | 1 | 2002 | 41 | 0.01 | Why? |
| Models, Biological | 1 | 2017 | 4907 | 0.01 | Why? |
| Viral Proteins | 1 | 2017 | 7370 | 0.01 | Why? |
| Industry | 1 | 2002 | 347 | 0.01 | Why? |
| Agriculture | 1 | 2002 | 367 | 0.01 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2017 | 13720 | 0.01 | Why? |
| Time Factors | 1 | 2018 | 31397 | 0.01 | Why? |
| Prospective Studies | 1 | 2017 | 43301 | 0.01 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2007 | 7868 | 0.01 | Why? |
| Child | 1 | 2017 | 70012 | 0.01 | Why? |